BRIEF-Cloudbreak Pharma Submits IND Application For Cbt-358 To FDA
مشاركة
May 22 (Reuters) - Cloudbreak Pharma Inc 2592.HK:
SUBMITS IND APPLICATION FOR CBT-358 TO FDA
Further company coverage: 2592.HK